SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-108283
Filing Date
2021-04-07
Accepted
2021-04-07 08:46:02
Documents
9
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d106749ddef14a.htm DEF 14A 632076
2 GRAPHIC g106749g01k50.jpg GRAPHIC 40419
3 GRAPHIC g106749g23k68.jpg GRAPHIC 26481
4 GRAPHIC g106749g25m69.jpg GRAPHIC 106836
5 GRAPHIC g106749g53d28.jpg GRAPHIC 44917
6 GRAPHIC g106749g55j41.jpg GRAPHIC 105040
7 GRAPHIC g106749g64n91.jpg GRAPHIC 46696
8 GRAPHIC g106749snap20.jpg GRAPHIC 253553
9 GRAPHIC g106749snap6.jpg GRAPHIC 575598
  Complete submission text file 0001193125-21-108283.txt   2286272
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 21810822
SIC: 2834 Pharmaceutical Preparations